Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism
16. Juli 2024 09:02 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Kuehn Law Encourages AGTI, GLT, NGM, and AA Investors to Contact Law Firm
26. Februar 2024 15:44 ET
|
KUEHN LAW, PLLC
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
11. Juli 2023 09:58 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...
THC Therapeutics Engage Milestone Management Services for Investor Relations
08. April 2021 07:20 ET
|
THC Therapeutics Inc
LAS VEGAS, April 08, 2021 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded health and technology company, whose mission statement is "Better Health through the...
THC Therapeutics Has Joined the Las Vegas Medical Marijuana Association.
04. Februar 2021 07:20 ET
|
THC Therapeutics Inc
The company will utilize the connections of the LVMMA to raise capital, and seek mergers & acquisitions. THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company,...
PBS SoCal and Page 124 Productions Present Bill W.: The Creative Force Behind Alcoholics Anonymous
19. September 2016 09:15 ET
|
PBS SoCal
LOS ANGELES, CA--(Marketwired - September 19, 2016) - PBS SoCal and Page 124 Productions, LLC, present Bill W.: The Creative Force Behind Alcoholics Anonymous, a documentary film about William G....